Dr. Amy Barton is a nephrology-trained clinical pharmacy scientist. She obtained her bachelor and doctorate degrees in pharmacy from Albany College of Pharmacy in Albany, NY. She completed a post-graduate general pharmacy residency at St. Peter’s Hospital in Albany, NY and a nephrology research fellowship at the University of Illinois at Chicago. Dr. Barton was a clinical and translational academic scientist for more than 20 years at several institutions, including the University of New Mexico and the University of Michigan. Her research program focused on evaluating commercially available iron-carbohydrate nanomedicines with regard to toxicity and biorelevant bioequivalence evaluation. She serves on several national and international workgroups focused on kidney disease and nanomedicine science, including Chair of the pharmacy work group for the National Institute of Health’s National Kidney Disease Education Program and the EU-US Nanomedicine Collaboratory.